114 related articles for article (PubMed ID: 37307296)
1. SPECT Imaging of Lysyl Oxidase-like 2 in a Model of Idiopathic Pulmonary Fibrosis.
Vizier R; Garnier AR; Dias A; Moreau M; Claron M; Collin B; Denat F; Bellaye PS; Goncalves V
Mol Pharm; 2023 Jul; 20(7):3613-3622. PubMed ID: 37307296
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of FAPα assessment in bronchoalveolar lavage as a marker of fibrogenesis: results of a preclinical study and first report in patients with idiopathic pulmonary fibrosis.
Lavis P; Pingitore J; Doumont G; Garabet A; Van Simaeys G; Lacroix S; Passon N; Van Heymbeek C; De Maeseneire C; Allard J; Collin A; Huaux F; Decaestecker C; Salmon I; Goldman S; Cardozo AK; Bondue B
Respir Res; 2023 Oct; 24(1):254. PubMed ID: 37880678
[TBL] [Abstract][Full Text] [Related]
3. [
Rosenkrans ZT; Massey CF; Bernau K; Ferreira CA; Jeffery JJ; Schulte JJ; Moore M; Valla F; Batterton JM; Drake CR; McMillan AB; Sandbo N; Pirasteh A; Hernandez R
Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3705-3716. PubMed ID: 35556159
[TBL] [Abstract][Full Text] [Related]
4. Absence of early metabolic response assessed by 18F-FDG PET/CT after initiation of antifibrotic drugs in IPF patients.
Bondue B; Castiaux A; Van Simaeys G; Mathey C; Sherer F; Egrise D; Lacroix S; Huaux F; Doumont G; Goldman S
Respir Res; 2019 Jan; 20(1):10. PubMed ID: 30646908
[TBL] [Abstract][Full Text] [Related]
5. [
Tanguy J; Goirand F; Bouchard A; Frenay J; Moreau M; Mothes C; Oudot A; Helbling A; Guillemin M; Bonniaud P; Cochet A; Collin B; Bellaye PS
Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3058-3074. PubMed ID: 33580818
[TBL] [Abstract][Full Text] [Related]
6. Preclinical SPECT/CT imaging of αvβ6 integrins for molecular stratification of idiopathic pulmonary fibrosis.
John AE; Luckett JC; Tatler AL; Awais RO; Desai A; Habgood A; Ludbrook S; Blanchard AD; Perkins AC; Jenkins RG; Marshall JF
J Nucl Med; 2013 Dec; 54(12):2146-52. PubMed ID: 24167080
[TBL] [Abstract][Full Text] [Related]
7. Extracellular Matrix Cross-Linking Enhances Fibroblast Growth and Protects against Matrix Proteolysis in Lung Fibrosis.
Philp CJ; Siebeke I; Clements D; Miller S; Habgood A; John AE; Navaratnam V; Hubbard RB; Jenkins G; Johnson SR
Am J Respir Cell Mol Biol; 2018 May; 58(5):594-603. PubMed ID: 29053339
[TBL] [Abstract][Full Text] [Related]
8. Heterogenous Intrapulmonary Distribution of Aerosolized Model Compounds in Mice with Bleomycin-Induced Pulmonary Fibrosis.
Togami K; Kanehira Y; Yumita Y; Ozaki H; Wang R; Tada H; Chono S
J Aerosol Med Pulm Drug Deliv; 2023 Dec; 36(6):289-299. PubMed ID: 37843890
[No Abstract] [Full Text] [Related]
9. Improvement of the pharmacokinetics and antifibrotic effects of nintedanib by intrapulmonary administration of a nintedanib-hydroxypropyl-γ-cyclodextrin inclusion complex in mice with bleomycin-induced pulmonary fibrosis.
Togami K; Ogasawara A; Irie S; Iwata K; Yamaguchi K; Tada H; Chono S
Eur J Pharm Biopharm; 2022 Mar; 172():203-212. PubMed ID: 35183716
[TBL] [Abstract][Full Text] [Related]
10. MicroSPECT Imaging-Guided Treatment of Idiopathic Pulmonary Fibrosis in Mice with a Vimentin-Targeting
Zhang D; Zhuang R; Li J; Lv Y; Yang X; Pan W; Zhang X
Mol Pharm; 2021 Nov; 18(11):4140-4147. PubMed ID: 34657437
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary fibrosis model of mice induced by different administration methods of bleomycin.
Gul A; Yang F; Xie C; Du W; Mohammadtursun N; Wang B; Le J; Dong J
BMC Pulm Med; 2023 Mar; 23(1):91. PubMed ID: 36944966
[TBL] [Abstract][Full Text] [Related]
12. Lysyl oxidase directly contributes to extracellular matrix production and fibrosis in systemic sclerosis.
Nguyen XX; Nishimoto T; Takihara T; Mlakar L; Bradshaw AD; Feghali-Bostwick C
Am J Physiol Lung Cell Mol Physiol; 2021 Jan; 320(1):L29-L40. PubMed ID: 33026236
[TBL] [Abstract][Full Text] [Related]
13. The Anti-fibrotic and Anti-inflammatory Potential of Bone Marrow-Derived Mesenchymal Stem Cells and Nintedanib in Bleomycin-Induced Lung Fibrosis in Rats.
Gad ES; Salama AAA; El-Shafie MF; Arafa HMM; Abdelsalam RM; Khattab M
Inflammation; 2020 Feb; 43(1):123-134. PubMed ID: 31646446
[TBL] [Abstract][Full Text] [Related]
14. Persistent, Progressive Pulmonary Fibrosis and Epithelial Remodeling in Mice.
Redente EF; Black BP; Backos DS; Bahadur AN; Humphries SM; Lynch DA; Tuder RM; Zemans RL; Riches DWH
Am J Respir Cell Mol Biol; 2021 Jun; 64(6):669-676. PubMed ID: 33406369
[TBL] [Abstract][Full Text] [Related]
15. The copper chelator tetrathiomolybdate regressed bleomycin-induced pulmonary fibrosis in mice, by reducing lysyl oxidase expressions.
Ovet H; Oztay F
Biol Trace Elem Res; 2014 Dec; 162(1-3):189-99. PubMed ID: 25349139
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of lysyl oxidase (like) family members in pulmonary fibrosis.
Aumiller V; Strobel B; Romeike M; Schuler M; Stierstorfer BE; Kreuz S
Sci Rep; 2017 Mar; 7(1):149. PubMed ID: 28273952
[TBL] [Abstract][Full Text] [Related]
17. N-acetylcysteine downregulation of lysyl oxidase activity alleviating bleomycin-induced pulmonary fibrosis in rats.
Li S; Yang X; Li W; Li J; Su X; Chen L; Yan G
Respiration; 2012; 84(6):509-17. PubMed ID: 23006535
[TBL] [Abstract][Full Text] [Related]
18. PET/CT with 18F-FDG- and 18F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis.
Bondue B; Sherer F; Van Simaeys G; Doumont G; Egrise D; Yakoub Y; Huaux F; Parmentier M; Rorive S; Sauvage S; Lacroix S; Vosters O; De Vuyst P; Goldman S
J Nucl Med; 2015 Jan; 56(1):127-32. PubMed ID: 25537989
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of
Hiroyama S; Matsunaga K; Ito M; Iimori H; Tajiri M; Nakano Y; Shimosegawa E; Abe K
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4358-4368. PubMed ID: 35876866
[TBL] [Abstract][Full Text] [Related]
20. Quantification of Lung Fibrosis in IPF-Like Mouse Model and Pharmacological Response to Treatment by Micro-Computed Tomography.
Ruscitti F; Ravanetti F; Bertani V; Ragionieri L; Mecozzi L; Sverzellati N; Silva M; Ruffini L; Menozzi V; Civelli M; Villetti G; Stellari FF
Front Pharmacol; 2020; 11():1117. PubMed ID: 32792953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
